PI3K inhibition leads to insulin resistance, interrupting glucose uptake in muscle and adipose tissue, thereby activating hepatic glycogenolysis, resulting in hyperglycemia and compensatory increase in insulin. The gene discussed is PIK3CA; the disease is Insulin resistance.